Published in EMBO J on August 15, 1996
A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol (2012) 2.81
Viral quasispecies evolution. Microbiol Mol Biol Rev (2012) 2.69
TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev (2010) 2.64
Structures of T cell immunoglobulin mucin protein 4 show a metal-Ion-dependent ligand binding site where phosphatidylserine binds. Immunity (2007) 2.29
The costimulatory role of TIM molecules. Immunol Rev (2009) 2.07
The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol (1998) 2.05
Living in the liver: hepatic infections. Nat Rev Immunol (2012) 2.03
Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci (2007) 1.94
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med (2007) 1.93
Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J Virol (1998) 1.83
Hepatitis A: old and new. Clin Microbiol Rev (2001) 1.82
The cell biology of receptor-mediated virus entry. J Cell Biol (2011) 1.75
TIM-1, a novel allergy and asthma susceptibility gene. Springer Semin Immunopathol (2003) 1.72
Tim-2 regulates T helper type 2 responses and autoimmunity. J Exp Med (2005) 1.63
Capsid functions of inactivated human picornaviruses and feline calicivirus. Appl Environ Microbiol (2003) 1.56
Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms. J Virol (1998) 1.55
Picornaviruses. Curr Top Microbiol Immunol (2010) 1.53
TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog (2013) 1.53
TIMs: central regulators of immune responses. J Exp Med (2008) 1.50
Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. J Virol (2013) 1.29
TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J Exp Med (2010) 1.29
Tim-1 is induced on germinal centre B cells through B-cell receptor signalling but is not essential for the germinal centre response. Immunology (2010) 1.24
The Cys-rich region of hepatitis A virus cellular receptor 1 is required for binding of hepatitis A virus and protective monoclonal antibody 190/4. J Virol (1998) 1.21
TIM-1 and TIM-3 proteins in immune regulation. Cytokine (2008) 1.16
Hepatitis A virus and the origins of picornaviruses. Nature (2014) 1.15
Cell adhesion molecules in the pathogenesis of and host defence against microbial infection. Mol Pathol (1999) 1.14
Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions. J Virol (2003) 1.11
Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells. Eur J Immunol (2011) 1.08
Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivity. J Immunol (2010) 1.08
Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma. J Clin Invest (2010) 1.06
Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol (2000) 1.06
99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: farm lifestyles and the hygiene hypothesis. Clin Exp Immunol (2010) 1.06
T cell Ig and mucin domain proteins and immunity. J Immunol (2010) 1.02
Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens ε-toxin. PLoS One (2011) 1.01
The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury. J Am Soc Nephrol (2011) 1.00
Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions. J Virol (2007) 1.00
Ciliary calcium signaling is modulated by kidney injury molecule-1 (Kim1). Pflugers Arch (2007) 0.98
Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1. J Virol (2001) 0.97
TIM family proteins promote the lysosomal degradation of the nuclear receptor NUR77. Sci Signal (2012) 0.94
Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane. J Virol (2004) 0.94
TIM-family proteins inhibit HIV-1 release. Proc Natl Acad Sci U S A (2014) 0.93
Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery. Microbiol Mol Biol Rev (2016) 0.91
Host cell factors in filovirus entry: novel players, new insights. Viruses (2012) 0.91
Characterization of replication-competent hepatitis A virus constructs containing insertions at the N terminus of the polyprotein. J Virol (1998) 0.91
Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humans. Gastroenterology (2012) 0.89
Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation. Am J Transplant (2012) 0.87
Vectorial entry and release of hepatitis A virus in polarized human hepatocytes. J Virol (2008) 0.87
TIM polymorphisms--genetics and function. Genes Immun (2011) 0.84
Fyn binds to and phosphorylates T cell immunoglobulin and mucin domain-1 (Tim-1). Mol Immunol (2011) 0.84
Regulation of T cell responses by the receptor molecule Tim-3. Immunol Res (2014) 0.84
Characterizing functional domains for TIM-mediated enveloped virus entry. J Virol (2014) 0.83
HAVCR1 gene haplotypes and infection by different viral hepatitis C virus genotypes. Clin Vaccine Immunol (2011) 0.83
The role of cellular adhesion molecules in virus attachment and entry. Philos Trans R Soc Lond B Biol Sci (2015) 0.83
Capsid and Infectivity in Virus Detection. Food Environ Virol (2009) 0.82
Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology. Biomed Res Int (2014) 0.81
The interaction of hepatitis A virus (HAV) with soluble forms of its cellular receptor 1 (HAVCR1) share the physiological requirements of infectivity in cell culture. Virol J (2009) 0.80
A single mutation in the glycophorin A binding site of hepatitis A virus enhances virus clearance from the blood and results in a lower fitness variant. J Virol (2012) 0.79
Expression and polymorphisms of T cell immunoglobulin domain and mucin domain protein-1 in thymoma with or without myasthenia gravis. Oncol Lett (2014) 0.79
Regulation of T-cell immunity by T-cell immunoglobulin and mucin domain proteins. Transplantation (2007) 0.78
The role of TIM-containing molecules in airway disease and their potential as therapeutic targets. J Inflamm Res (2012) 0.78
The role of T cell immunoglobulin mucin domains 1 and 4 in a herpes simplex virus-induced Behçet's disease mouse model. Mediators Inflamm (2013) 0.76
G protein, 12 (Gα12) is a negative regulator of kidney injury molecule-1-mediated efferocytosis. Am J Physiol Renal Physiol (2015) 0.75
Hepatitis A virus (HAV) packaging size limit. Virol J (2009) 0.75
Distinct Trafficking of Cell Surface and Endosomal TIM-1 to the Immune Synapse. Traffic (2015) 0.75
Hepatitis A virus exhibits a structure unique among picornaviruses. Protein Cell (2015) 0.75
Potent neutralization of hepatitis A virus reveals a receptor mimic mechanism and the receptor recognition site. Proc Natl Acad Sci U S A (2017) 0.75
Differential Binding of the HIV-1 Envelope to Phosphatidylserine Receptors. Biochim Biophys Acta (2017) 0.75
Role of TIM-4 in exosome-dependent entry of HIV-1 into human immune cells. Int J Nanomedicine (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Basic local alignment search tool. J Mol Biol (1990) 659.07
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
A new method for predicting signal sequence cleavage sites. Nucleic Acids Res (1986) 37.19
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26
Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci U S A (1987) 12.15
Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc Natl Acad Sci U S A (1987) 10.38
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature (1988) 8.32
Why are proteins O-glycosylated? Trends Biochem Sci (1990) 4.68
Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect Immun (1981) 3.18
Mucin-type glycoproteins. Crit Rev Biochem Mol Biol (1992) 3.07
Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol (1981) 3.01
Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol (1987) 2.83
Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol (1992) 2.74
The use of sodium dodecyl sulfate in studies on the interaction of poliovirus and HeLa cells. Virology (1962) 2.62
DNA sequences, gene regulation and modular protein evolution in the Drosophila 68C glue gene cluster. J Mol Biol (1983) 2.57
High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol (1992) 2.44
Production of a monoclonal antibody against an epitope on HeLa cells that is the functional poliovirus binding site. J Gen Virol (1985) 2.08
The AGA1 product is involved in cell surface attachment of the Saccharomyces cerevisiae cell adhesion glycoprotein a-agglutinin. Mol Cell Biol (1991) 2.01
Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J (1994) 1.76
Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5). J Biol Chem (1994) 1.62
Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J Biol Chem (1994) 1.44
Mucins: structure, function, and associations with malignancy. Bioessays (1992) 1.40
A new repetitive protein from Xenopus laevis skin highly homologous to pancreatic spasmolytic polypeptide. J Biol Chem (1988) 1.32
MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism. J Clin Invest (1991) 1.26
Susceptibility of nonprimate cell lines to hepatitis A virus infection. J Virol (1994) 1.23
Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle. J Virol (1989) 1.23
P-domains as shuffled cysteine-rich modules in integumentary mucin C.1 (FIM-C.1) from Xenopus laevis. Polydispersity and genetic polymorphism. J Biol Chem (1992) 1.22
Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions. J Gen Virol (1985) 1.18
The core polypeptide of cystic fibrosis tracheal mucin contains a tandem repeat structure. Evidence for a common mucin in airway and gastrointestinal tissue. J Clin Invest (1990) 1.16
A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain. J Virol (1992) 1.11
Restricted replication of hepatitis A virus in cell culture: encapsidation of viral RNA depletes the pool of RNA available for replication. J Virol (1988) 1.07
Variants of a Leishmania surface antigen derived from a multigenic family. J Biol Chem (1991) 1.05
Simian hepatitis A virus (HAV) strain AGM-27: comparison of genome structure and growth in cell culture with other HAV strains. J Gen Virol (1991) 1.05
Hepatitis A virus attachment to cultured cell lines. J Infect Dis (1991) 1.03
Targeting of oncoproteins to membranes by fatty acylation. J Cell Sci Suppl (1989) 1.02
A cluster type organization of the loci of the immunoglobulin light chain in Atlantic cod (Gadus morhua L.) and rainbow trout (Oncorhynchus mykiss Walbaum) indicated by nucleotide sequences of cDNAs and hybridization analysis. Immunogenetics (1993) 0.98
Virus-binding activity of fibronectin: masking of hepatitis A virus. J Virol Methods (1984) 0.97
Parameters influencing the attachment of hepatitis A virus to a variety of continuous cell lines. J Gen Virol (1991) 0.96
Identification of virus components in circulating immune complexes isolated during hepatitis A virus infection. Hepatology (1990) 0.95
Isolation of hepatitis A virus in vitro in cell culture directly from human specimens. Proc Soc Exp Biol Med (1981) 0.93
Monoclonal antibodies against an immunodominant and neutralizing epitope on hepatitis A virus antigen. Arch Virol (1990) 0.87
Expression of MUC2 gene is down-regulated by vitamin A at the transcriptional level in vitro in tracheobronchial epithelial cells. Am J Respir Cell Mol Biol (1994) 0.87
Study of the chemical nature of Frp/3 cell recognition units for hepatitis A virus. Med Microbiol Immunol (1987) 0.85
An unusually small gene encoding a putative mucin-like glycoprotein in Trypanosoma cruzi. Gene (1994) 0.84
Appearance of immune complexes during experimental hepatitis A infection in chimpanzees. J Med Virol (1988) 0.82
Glue protein genes in Drosophila virilis: their organization, developmental control of transcription and specific mRNA degradation. Development (1990) 0.80
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci (2001) 10.38
Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol (1993) 8.47
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science (1997) 7.53
Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol (1993) 6.36
Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science (1973) 5.82
Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. J Virol (2000) 5.26
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol (2001) 5.25
Margaret Thatcher: a new illusion. Perception (1980) 4.59
Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. J Virol (1996) 4.59
A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A (1993) 4.30
Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15
Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1989) 3.67
Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A (2004) 3.57
A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody. J Immunol (1976) 3.53
Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol (1993) 3.37
Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31
Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J Clin Microbiol (1989) 3.19
Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect Immun (1981) 3.18
Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies. Jpn J Exp Med (1974) 3.08
Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet (1996) 3.08
Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med (1997) 3.04
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92
Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol (1987) 2.83
Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart (2002) 2.83
Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis (1977) 2.80
Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med (1990) 2.79
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science (1979) 2.78
Regional spatial normalization: toward an optimal target. J Comput Assist Tomogr (2001) 2.74
Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol (1992) 2.74
Starch granule-bound adenosine diphosphate glucose-starch glucosyltransferases of maize seeds. J Biol Chem (1966) 2.69
A four-dimensional probabilistic atlas of the human brain. J Am Med Inform Assoc (2001) 2.64
Enzyme-linked immunosorbent assay for detection of hepatitis A antigen in stool and antibody to hepatitis A antigen in sera: comparison with solid-phase radioimmunoassay, immune electron microscopy, and immune adherence hemagglutination assay. J Clin Microbiol (1978) 2.64
Detection of flaviviruses by reverse-transcriptase polymerase chain reaction. J Med Virol (1991) 2.59
Quality of care in private sector and NHS facilities for people with dementia: cross sectional survey. BMJ (2001) 2.59
Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis (2008) 2.58
Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A (1987) 2.56
Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis (1998) 2.46
Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology (1996) 2.44
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Clinical and serological analysis of transfusion-associated hepatitis. Lancet (1975) 2.41
Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination. J Virol (1991) 2.36
Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome. Nat Genet (1994) 2.35
Purification of hepatitis A antigen from feces and detection of antigen and antibody by immune adherence hemagglutination. Infect Immun (1976) 2.27
Chiropractor in medical school sees value in interdependence. Can Med Assoc J (1975) 2.20
Intraocular pressure change measured by Goldmann tonometry after laser in situ keratomileusis. J Cataract Refract Surg (1998) 2.18
Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ (1992) 2.12
Oxygen and hydrogen isotopic ratios in plant cellulose. Science (1977) 2.10
Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet (1997) 2.06
The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol (1998) 2.05
Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04
Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res (2000) 2.02
An optimized individual target brain in the Talairach coordinate system. Neuroimage (2002) 2.01
Detection of hepatitis A antigen by immunofluorescence. Infect Immun (1977) 2.00
The molecular virology of hepatitis C. Hepatology (1997) 2.00
Induction of delayed hypersensitivity to influenza and mumps viruses in mice. J Immunol (1969) 1.99
Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res (1999) 1.97
Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med (1977) 1.95
Will elderly rest home residents wear hip protectors? Age Ageing (1998) 1.95
Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol (1999) 1.93
Simultaneous multianalyte ELISA performed on a microarray platform. Clin Chem (2001) 1.89
Taxonomic classification of hepatitis A virus. Intervirology (1983) 1.87
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology (2000) 1.85
Pyruvate dehydrogenase complex from higher plant mitochondria and proplastids. Plant Physiol (1977) 1.85
Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology (1991) 1.82
Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J Virol (1994) 1.80
Perceived rate of movement depends on contrast. Vision Res (1982) 1.79
Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest (1991) 1.77
Impact of a national educational campaign to reduce patient delay in possible heart attack. Aust N Z J Med (1993) 1.75
CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol (1995) 1.72
An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol (1994) 1.68
Serotype-cross-reactive immunoglobulin M responses in dengue virus infections determined by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (2000) 1.67
Human speed perception is contrast dependent. Vision Res (1992) 1.66
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med (1972) 1.64
Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. Am J Psychiatry (1994) 1.64
Acute orbital cellulitis due to gas-forming bacteria. Eye (Lond) (1991) 1.61
Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis (1993) 1.60
Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol Med (1994) 1.57
Faecal shedding of hepatitis-A antigen. Lancet (1975) 1.54
Retracted Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model. Proc Natl Acad Sci U S A (2000) 1.51
Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice. Gastroenterology (1997) 1.50
Hepatitis B core antigen. Detection of antibody by radioimmunoprecipitation. J Immunol (1975) 1.50
Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men. J Clin Microbiol (2006) 1.46
Changes in cardiac output after acute blood loss and position change in man. Crit Care Med (1989) 1.45
Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood (1998) 1.45
Attenuation and cell culture adaptation of hepatitis A virus (HAV): a genetic analysis with HAV cDNA. J Virol (1989) 1.45
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med (2016) 1.41
Three-dimensional mapping of gyral shape and cortical surface asymmetries in schizophrenia: gender effects. Am J Psychiatry (2001) 1.41
Drug-induced supraglottic dystonia and spasmodic dysphonia. Mov Disord (1998) 1.40
The diagnostic accuracy of bedside and laboratory coagulation: procedures used to monitor the anticoagulation status of patients treated with heparin. Am J Clin Pathol (1998) 1.39
CRASH syndrome: mutations in L1CAM correlate with severity of the disease. Neuropediatrics (1997) 1.39
Aggregation of enterovirus small plaque variants and polioviruses under low ionic strength conditions. J Gen Virol (1978) 1.37
Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med (1991) 1.36
Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun (1983) 1.35
Focal structural changes and cognitive dysfunction in juvenile myoclonic epilepsy. Neurology (2011) 1.33